The Cannigma

MARCH 25, 2021

When the law changed in the UK in 2018, I was humbled by the efforts of those who suffer on a daily basis to achieve legal access to medicinal cannabis. The lively discussion highlighted how effective cannabis can be for managing not only pain , but also the often accompanying conditions of anxiety , low mood , and poor sleep.

Patients 145

Patients Clinical Trials Medicine Events 145

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. One of the more extensive reports of this nature was published in the Journal of Cannabis Research in 2018.

Education 101

Education Clinical Trials Medicine Policy 101

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

After securing FDA approval in June of 2018, Epidiolex’s manufacturer GW Pharma announced the drug should enter the consumer market by the end of 2018. Children who suffer from these conditions generally experience social and developmental delays due to constant seizures. Cannabis Legalization Throughout The Country.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. References Staff, T.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. Diversified Drug Development.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Cannabis Law Report

DECEMBER 14, 2019

In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. million in the Melbourne cannabis firm in 2018. A 2018 report from Prohibition Partners has forecasted that medical cannabis in Australia could be worth US$2.13

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

The Cannigma

MAY 9, 2023

However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes. 1 Hemp in Jordan In 2018, the Jordanian government legalized the cultivation of industrial hemp for certain purposes, such as the production of textiles and building materials.

Law 52

Law Clinical Trials Chronic Pain Recreational 52

Veriheal

JULY 12, 2021

As a veteran, being able to get past the PTSD involves transitioning out of the mental and emotional war zone, which is challenging and the reason why veterans seek out multiple methods to deal with the condition. Dr. McNabb and team also mentioned a study conducted in 2018 by Shishko and colleagues.

Treatment 105

Treatment Sleep Clinical Trials Data 105

The Cannigma

MAY 6, 2021

Technically speaking, it’s not produced by the plant, but is rather a degradation product of delta-9-THC, often as a result of aging and storage conditions. The popularity of hemp can be traced back to the 2018 Farm Bill, a piece of legislation that effectively legalized hemp, which is defined as cannabis containing less than 0.3%

THC 145

THC Cannabinoids Concentrates Hemp 145

MMJ Recs

NOVEMBER 20, 2023

Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain. Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

CannaMD

NOVEMBER 6, 2019

In the fall of 2018, scientists at the San Francisco Veterans Affairs Medical Center released findings from a survey on the subject of marijuana versus opioids. billion opioid prescriptions written between 2011 and 2018. Using Cannabis to Quit Opioids. percent, respectively.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . Epilepsy & behavior case reports 9 (2018): 10.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

CannaMD

AUGUST 26, 2020

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Conditioned place preference. mice/rats). The studies were then broken into eight categories: Cocaine self-administration. Brain-stimulation reward. Hepatic protection.

Therapy 98

Therapy CBD Research and Development Treatment 98

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

MARCH 4, 2020

In recent years, the United States has seen a proliferation of ketamine clinics. From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs.

Therapy 101

Therapy Legalization Chronic Pain DEA 101

Cannabis Law Report

OCTOBER 20, 2021

Mr Blunt said it had “exciting potential” for the treatment of mental health conditions such as depression, trauma and addiction. It would then potentially be in the same category as medical cannabis, which was legalised in 2018.

Supply Chain 52

Supply Chain Clinical Trials Therapy Treatment 52

Weedistry

FEBRUARY 4, 2019

Currently, 33 states along with the District of Columbia, Guam and Puerto Rico have passed laws for comprehensive medical cannabis programs — but critics often point out we’re lacking definitive proof that marijuana safely and effectively treats many of the qualifying conditions. There are two things wrong with this argument.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

SpeedWeed

MARCH 30, 2021

Anthony Ordman is Honorary Medical Director of Integro Medical Clinics – one of the 20-plus private clinics to have emerged since the law change in 2018. He would like to see the registry opened up to the private sector and believes the restricted conditions available for treatment through the NHS will limit its effectiveness.

Data 52

Data Patients Clinical Trials Business 52

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. This can help change the way people look at the substance. School: The University of Rhode Island.

Research and Development 119

Research and Development Education Agriculture Patients 119

CannaMD

NOVEMBER 8, 2019

A 2009 Canadian clinical trial of synthetic cannabinoid medication, nabilone , found: The majority of patients (72%) receiving nabilone experienced either cessation of nightmares or a significant reduction in nightmare intensity. Medical marijuana may also play a role in treating nightmares. You’re Not Alone.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

The 2018 Farm Bill, which approved the production of industrial hemp and cleared the way for CBD products, states that products produced from plants containing less than 0.3% CBN has the potential to treat many other conditions. CBN is believed to relieve symptoms of conditions in which seizures are a symptom, including epilepsy.

Sleep 94

Sleep Cannabinoids THC CBD 94

Cannabis Law Report

AUGUST 26, 2019

Over the years, research has generated results to suggest that marijuana benefits in the treatment of some conditions. The drug for treating such conditions involves a purified form of CBD. The approval is based on the research and clinical trials. Let us have a look at those. Chronic pain. CBD occurs in cannabis.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

CannaMD

AUGUST 8, 2020

More recently, the 2018 Farm Bill expanded hemp legislation. 27, 2018, the DEA announced a rule change that placed “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 On June 25, 2018, Epidiolex became the first FDA approved cannabis-derived medication to hit U.S. In 1970, the U.S.

CBD 105

CBD DEA Research and Development Hemp 105

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Lophora is a drug-development company founded in 2018 in Copenhagen, Denmark. Lophora – www.lophora.com.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Cannabis Law Report

JANUARY 3, 2022

in 2018, and we believe ANEB-001 holds potential to reverse symptoms safely and rapidly.”. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study at a single site in the Netherlands to evaluate ANEB-001 in the inhibition of THC-induced effects. Anebulo Pharmaceuticals, Inc. Rex Merchant.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

The Cannigma

JUNE 15, 2021

More and more CBD products on the market promise relief from pain, depression, anxiety, neurodegenerative conditions, and a plethora of other symptoms and conditions. In 2018, the US government passed the Farm Bill, which excluded hemp from the definition of marijuana plants, which remain illegal under federal law. Easy access.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

NOVEMBER 29, 2019

Lack of clinical trials is a major reason why doctors are cautious about the drug. In 2018, after the law was passed, doctors issued approximately 142,000 prescriptions for medical marijuana only. But according to Schubert, health actors and lawmakers are also often simply not familiar with medical marijuana. Read full story.

Medicine 45

Medicine Clinical Trials Treatment Access 45

Cannabis Law Report

NOVEMBER 29, 2021

ATAI Life Sciences AG (NASDAQ: ATAI), the innovative mental health platform company I have started in 2018 and which is committed to unlocking the compelling potential of psychedelics, has announced this morning that it has bought an additional stake in COMPASS Pathways (NASDAQ: CMPS), bringing atai’s ownership in Compass beyond 20%.

Treatment 52

Treatment Clinical Trials Data Patients 52

The Joint Blog

AUGUST 27, 2020

According to NORML, their findings are consistent with a pair of prior studies – one from 2018 and one from earlier this year – similarly reporting reduced rates of hospitalization among SCD patients who initiate cannabis therapy. ” That study’s authors concluded: “People with SCD are often using multiple medications.

Patients 49

Patients Clinical Trials Data Therapy 49

Cannabis Info

OCTOBER 11, 2019

Dementia is a catch-all term for the conditions that cause declining memory and thinking skills, including Alzheimer’s, Parkinson’s and vascular dementia. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. Cannabis research in the U.S.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

The Joint Blog

NOVEMBER 4, 2019

We conducted an electronic survey of primary care providers in a large Minnesota-based healthcare system between January 23 and February 5, 2018. believed that providers should be offering to patients for managing medical conditions. ” The full abstract of the study can be found below: Background. A majority (>?50%)

Therapy 42

Therapy Clinical Trials Conditions Patients 42

Cannabis Law Report

JANUARY 4, 2022

“I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S. Anebulo Pharmaceuticals, Inc. Rex Merchant. 512) 598-0931.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

SEPTEMBER 1, 2019

The Victorian and New South Wales Governments had both begun clinical trials of cannabis products for children with severe epilepsy and for palliative care, respectively. Nine months after the election of the Marshall Government in 2018, LeafCann organised the first Future of Medicinal Cannabis symposium in Adelaide.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

MMJ Recs

JULY 3, 2024

The prevalence of anxiety disorders and stress-related conditions has risen significantly in recent decades. Federally, the 2018 Farm Bill decriminalized hemp-derived CBD with less than 0.3% Additionally, CBD has anti-inflammatory and antioxidant properties, which may contribute to its therapeutic effects on stress-related conditions.

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

SEPTEMBER 24, 2019

Epidyolex has been approved as a treatment option for children as young as two with Lennox-Gastaut syndrome or Dravet syndrome – difficult-to-treat conditions that can cause multiple seizures a day. The use of ones containing THC was legalised across the UK in November 2018. In June 2018 GW, along with its U.S.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55